0001593968-18-001323.txt : 20181009 0001593968-18-001323.hdr.sgml : 20181009 20181009160309 ACCESSION NUMBER: 0001593968-18-001323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181004 FILED AS OF DATE: 20181009 DATE AS OF CHANGE: 20181009 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Colangelo Dominick CENTRAL INDEX KEY: 0001313403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 181113664 MAIL ADDRESS: STREET 1: 1000 WINTER ST. STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2018-10-04 0000887359 Vericel Corp VCEL 0001313403 Colangelo Dominick C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true true false false President and CEO Common Stock 2018-10-04 4 M false 75000 1.95 A 150163 D Common Stock 2018-10-04 4 S false 75000 15.02 D 75163 D Stock Option (right to buy) 1.95 2018-10-04 4 M false 75000 0 D 2026-02-09 Common Stock 75000 72188 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018. These options, representing the right to purchase a total of 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. /s/ Dominick C. Colangelo 2018-10-09